Location: Home
  • search
  • go
  • Relate News
  • 10/1/2019FiercePharma: Big Pharma CEOs' Chinese Names
  • 10/1/2019Central Government Issues Implementation Opinions for Expanding 4+7 Tr...
  • 9/30/2019Pharma Industry Face Unprecedented Price Pressure in Expanded 4+7 Tend...
  • 9/30/2019Financial-related Company News in Brief
  • 9/30/2019Eisai and Nichi-Iko Enter Partnership for Generic Drugs in China
  • 9/30/2019Central Government Issues New Policy for Healthcare Sector Development...
  • 9/30/2019Chinese Health Authorities Pledge to Prioritize Rural Development
  • 9/30/2019CFC Launches Chinese Lung Cancer Knowledge Platform
  • 9/30/2019Erbitux 1L with FOLFOX or FOLFIRI Approved in China for RAS Wild-type ...
  • 9/30/2019CDE Seeks Comments on Implementation Suggestions for ICH Q Series Guid...
  • 9/30/2019CDE Seeks Comments on Draft Chinese Translations of ICH E2A Guideline
  • 9/29/2019Kalbe Genexine Biologics Enters Exclusive Licensing of Henlius's I/O P...
  • 9/27/2019NHSA Sets Timeline for Phasing Out Provincial Level Additions of NRDL
  • 9/27/2019Recent Executive Moves
  • 9/27/2019AstraZeneca’s Lung Cancer Drug Receives Regulatory Approval In China
  • 9/27/2019NMPA Confirms Withdrawal of GMP and GSP Certifications, Pledging Timel...
  • 9/26/2019As Tariffs Affect the Pharma Industry, Business Strategies Must Evolve
  • 9/26/2019India and China Spark Concerns for UK Drug Supplies
  • 9/26/2019Thermo Fisher Scientific Expands Clinical Trials Capabilities and Anno...
  • 9/26/2019Sanofi, AZ, Lilly and More Win Business in China's Expanded Cut-price ...
  • 9/26/2019NHSA: BMI Reimbursed Nearly CNY 2B for 17 Anticancers in H1
  • 9/25/2019CDE Solicits Comments over Two Guidelines on Clinical Data Monitoring ...
  • 9/25/2019NMPA Officially Joins IMDRF NCAR Exchange Program
  • 9/24/2019China to Promote Vaccination against Cervical Cancer
  • 9/24/2019China's Tech Giants Take a Shot at Reinventing Health Care
  • 9/24/2019Mitsubishi Tanabe Files for Tenelia (Teneligliptin) Approval in China
  • 9/24/2019Helsinn and Mundipharma Jointly Announce NMPA's Approval of Oral Formu...
  • 9/24/2019NMPA Co-sponsors 5th China-ASEAN Summit for Drug Development and Coope...
  • 9/24/2019Caixin: Dr Reddy’s Is First Indian Drugmaker Accepted by China's 4+7 ...
  • 9/24/2019Bloomberg: China’s Drug-Price Cuts Pressure Lipitor and Other Foreign...
  • Page:294/803 Total number of articles:24081: [First][<<] [292] [293] [294] [295] [296] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group